-
公开(公告)号：EP3610731A1
公开(公告)日：2020-02-19
申请号：EP19187649.9
申请日：2012-07-27
申请人： Medivation Prostate Therapeutics LLC , The Regents of the University of Colorado, a body corporate
IPC分类号： A01N47/28 , A61K31/17 , A61P35/00 , A61K31/4166 , A61K31/4184
摘要： The disclosure describes the use of one or more compounds that fall within the scope of one or more of structural formulae I, II, III, IV, V, or VI for treating triple negative breast Compounds useful for treating breast cancer include those compounds of formulae I, II, III, IV, V, or VI that inhibit proliferation of breast cancer cells and/or lead to the death of breast cancer cells, especially triple negative breast cancer.
-
公开(公告)号：EP3329775A1
公开(公告)日：2018-06-06
申请号：EP18153287.0
申请日：2011-02-24
发明人： THOMPSON, Andrew , LAMBERSON, Carol , GREENFIELD, Scott , JAIN, Rajendra Parasmal , ANGELAUD, Remy
IPC分类号： A01N43/50 , A61K31/415 , C07D233/86 , C07D235/02 , C07C237/30
CPC分类号： C07D233/86 , C07C231/12 , C07C237/30 , C07D235/02
摘要： Processes are provided for the synthesis of diarylthiohydantoin and diarylhydantoin compounds, such as compounds of the formula:
wherein X, Y 1 , Y 2 , R 1 , and R 2 are as defined herein. Medicinal products containing the same find particular use in treating prostate cancer, including castration-resistant prostate cancer and/or hormone-sensitive prostate cancer.-
公开(公告)号：EP4169908A1
公开(公告)日：2023-04-26
申请号：EP22197255.7
申请日：2013-09-11
发明人： LORENZ, Douglas Alan , KONAGURTHU, Sanjay , WALD, Randy J. , EVERETT, Jason A. , MATZ, Sheila , TAKAISHI, Yuuki , SAKAI, Toshiro , IRIE, Ryousuke , OBA, Shinsuke , TOYOTA, Hiroyasu , NISHIMURA, Koji , KANBAYASHI, Atsushi
IPC分类号： C07D233/86 , A61K31/4166 , A61P35/00 , A61K9/14 , A61K9/20 , A61K9/16 , A61P13/08 , A61P15/00 , A61P15/08 , A61P15/14 , A61P43/00
摘要： This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
4.发明授权PROCESSES FOR THE SYNTHESIS OF DIARYLTHIOHYDANTOIN AND DIARYLHYDANTOIN COMPOUNDS 有权合成二芳基硫代嘌呤和二萘醌化合物的方法
公开(公告)号：EP2538785B1
公开(公告)日：2018-03-21
申请号：EP11748095.4
申请日：2011-02-24
发明人： THOMPSON, Andrew , LAMBERSON, Carol , GREENFIELD, Scott , JAIN, Rajendra, Parasmal , ANGELAUD, Remy
IPC分类号： A01N43/50 , A61K31/415 , C07D233/86 , C07D235/02
CPC分类号： C07D233/86 , C07C231/12 , C07C237/30 , C07D235/02
摘要： Processes are provided for the synthesis of diarylthiohydantoin and diarylhydantoin compounds. Medicinal products containing the same find particular use in treating prostate cancer, including castration-resistant prostate cancer and/or hormone-sensitive prostate cancer.
-
公开(公告)号：EP3791724A1
公开(公告)日：2021-03-17
申请号：EP20191500.6
申请日：2012-07-27
申请人： Medivation Prostate Therapeutics LLC , The Regents of the University of Colorado, a body corporate
IPC分类号： A01N47/28 , A61K31/17 , A61P35/00 , A61K31/4166 , A61K31/4184
摘要： The disclosure describes the use of one or more compounds that fall within the scope of one or more of structural formulae I, II, III, IV, V, or VI for treating triple negative breast Compounds useful for treating breast cancer include those compounds of formulae I, II, III, IV, V, or VI that inhibit proliferation of breast cancer cells and/or lead to the death of breast cancer cells, especially triple negative breast cancer.
-
公开(公告)号：EP2739153B1
公开(公告)日：2018-08-22
申请号：EP12846720.6
申请日：2012-07-27
申请人： Medivation Prostate Therapeutics LLC , The Regents of the University of Colorado, a body corporate
IPC分类号： A01N47/28 , A61K31/17 , A61P35/00 , A61K31/4166 , A61K31/4184
CPC分类号： A61K31/4184 , A61K31/4166
摘要： The disclosure describes the use of one or more compounds that fall within the scope of one or more of structural formulae I, II, III, IV, V, or VI for treating triple negative breast Compounds useful for treating breast cancer include those compounds of formulae I, II, III, IV, V, or VI that inhibit proliferation of breast cancer cells and/or lead to the death of breast cancer cells, especially triple negative breast cancer.
-
公开(公告)号：EP4324527A2
公开(公告)日：2024-02-21
申请号：EP23205739.8
申请日：2013-09-11
发明人： LORENZ, Douglas Alan , KONAGURTHU, Sanjay , WALD, Randy J. , EVERETT, Jason A. , MATZ, Sheila , TAKAISHI, Yuuki , SAKAI, Toshiro , IRIE, Ryousuke , OBA, Shinsuke , TOYOTA, Hiroyasu , NISHIMURA, Koji , KANBAYASHI, Atsushi
IPC分类号： A61P43/00
摘要： This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号：EP3971167A1
公开(公告)日：2022-03-23
申请号：EP21190086.5
申请日：2013-09-11
发明人： LORENZ, Douglas Alan , KONAGURTHU, Sanjay , WALD, Randy J. , EVERETT, Jason A. , MATZ, Sheila , TAKAISHI, Yuuki , SAKAI, Toshiro , IRIE, Ryousuke , OBA, Shinsuke , TOYOTA, Hiroyasu , NISHIMURA, Koji , KANBAYASHI, Atsushi
IPC分类号： C07D233/86 , A61K31/4166 , A61P35/00 , A61K9/14 , A61K9/20 , A61K9/16 , A61P13/08 , A61P15/00 , A61P15/08 , A61P15/14 , A61P43/00
摘要： This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号：EP3725778A1
公开(公告)日：2020-10-21
申请号：EP20177837.0
申请日：2013-09-11
发明人： LORENZ, Douglas Alan , KONAGURTHU, Sanjay , WALD, Randy J. , EVERETT, Jason A. , MATZ, Sheila , TAKAISHI, Yuuki , SAKAI, Toshiro , IRIE, Ryousuke , OBA, Shinsuke , TOYOTA, Hiroyasu , NISHIMURA, Koji , KANBAYASHI, Atsushi
IPC分类号： C07D233/86 , A61K31/4164 , A61P35/00 , A61K31/4166 , A61K9/16 , A61P13/08 , A61P15/00 , A61P15/08 , A61P15/14 , A61P43/00
摘要： This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号：EP4450130A2
公开(公告)日：2024-10-23
申请号：EP24198653.8
申请日：2013-09-11
发明人： Lorenz, Douglas Alan , Konagurthu, Sanjay , Wald, Randy J. , Everett, Jason A. , Matz, Sheila , Takaishi, Yuuki , Sakai, Toshiro , Irie, Ryousuke , Oba, Shinsuke , Toyota, Hiroyasu , Nishimura, Koji , Kanbayashi, Atsushi
IPC分类号： A61P43/00
摘要： This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
-
-
-
-
-
-
-
-
搜索结果
13 条记录 (耗时 0.019 秒)
